PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17409437-2	2007	Tolfenamic acid, a nonsteroidal anti-inflammatory drug, decreases Sp protein expression in Panc-1 and L3.6pl pancreatic cancer cells, and this was accompanied by decreased VEGFR1 protein and mRNA and decreased luciferase activity on cells transfected with constructs (pVEGFR1) containing VEGFR1 promoter inserts.	tolfenamic acid	0-15	fms related receptor tyrosine kinase 1	Homo sapiens	172-178	
17409437-2	2007	Tolfenamic acid, a nonsteroidal anti-inflammatory drug, decreases Sp protein expression in Panc-1 and L3.6pl pancreatic cancer cells, and this was accompanied by decreased VEGFR1 protein and mRNA and decreased luciferase activity on cells transfected with constructs (pVEGFR1) containing VEGFR1 promoter inserts.	tolfenamic acid	0-15	fms related receptor tyrosine kinase 1	Homo sapiens	269-275	
17409437-4	2007	These results show that VEGFR1 is regulated by Sp proteins and that treatment with tolfenamic acid decreases expression of this critical angiogenic factor.	tolfenamic acid	83-98	fms related receptor tyrosine kinase 1	Homo sapiens	24-30	
17409437-5	2007	Moreover, in vitro studies in Panc-1 cells show that activation of VEGFR1 by VEGFB to increase mitogen-activated protein kinase 1/2 phosphorylation and cell migration on collagen-coated plates is also inhibited by tolfenamic acid.	tolfenamic acid	214-229	fms related receptor tyrosine kinase 1	Homo sapiens	67-73